{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:16Z","timestamp":1792814116276,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>To compare sub-Tenon\u2019s (\u201cdropless\u201d) and topical steroid regimens for inflammation prophylaxis following cataract surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects\/methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted using the electronic health record (EHR) of a single academic medical centre in Philadelphia, Pennsylvania, USA. All patients who underwent phacoemulsification cataract surgeries from January 1, 2023, to August 31, 2024 were analysed. Eyes in the dropless group received an intraoperative sub-Tenon\u2019s triamcinolone acetonide (TA) injection. Eyes in the topical group followed a routine postoperative topical steroid taper (prednisolone acetate 1% drops). Baseline characteristics included age, race, and relevant comorbidities. Key outcomes assessed were incidence of intraocular pressure (IOP) spikes greater than 35\u2009mmHg, cystoid macular oedema (CMO), and rebound iritis. Differences were analysed with Fisher\u2019s exact tests and linear regressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 3307 eyes were included (291 treated with the dropless protocol and 3016 with topical drops). Baseline patient characteristics were similar between groups in terms of age, sex, and comorbidities, with the exception that the dropless cohort had a higher proportion of Black patients (46.0% vs 34.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and diabetic patients (40.5% vs. 30.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). There were no significant differences between dropless and topical groups in the incidence of IOP spikes &gt;35\u2009mmHg, CMO, or rebound iritis (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sub-Tenon\u2019s TA was noninferior to topical steroids in terms of incidence of IOP spikes, CMO, and rebound iritis following cataract surgery. However, further research is needed to identify risk factors for adverse outcomes and determine ideal use cases for a dropless protocol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04309-3","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:01:11Z","timestamp":1771516871000},"page":"848-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dropless cataract surgery: comparing sub-Tenon\u2019s and topical steroids for postoperative inflammation prophylaxis"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7236-5254","authenticated-orcid":false,"given":"Alan Y.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Sulewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1189-2510","authenticated-orcid":false,"given":"Stephen","family":"Armenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"4309_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/03036758.2020.1714673","volume":"50","author":"CNJ McGhee","year":"2020","unstructured":"McGhee CNJ, Zhang J, Patel DV. A perspective of contemporary cataract surgery: the most common surgical procedure in the world. J R Soc N Z. 2020;50:245\u201362.","journal-title":"J R Soc N Z"},{"key":"4309_CR2","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2021.10.006","volume":"129","author":"KM Miller","year":"2022","unstructured":"Miller KM, Oetting TA, Tweeten JP, Carter K, Lee BS, Lin S, et al. Cataract in the adult eye preferred practice pattern\u00ae. Ophthalmology. 2022;129:P1\u2013P126.","journal-title":"Ophthalmology"},{"key":"4309_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4103\/ijo.IJO_1186_19","volume":"68","author":"N Bardoloi","year":"2020","unstructured":"Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol. 2020;68:1081.","journal-title":"Indian J Ophthalmol"},{"key":"4309_CR4","doi-asserted-by":"crossref","unstructured":"Matossian C. Noncompliance with prescribed eyedrop regimens among patients undergoing cataract surgery\u2014prevalence, consequences, and solutions. 2020. Available at: https:\/\/www.touchophthalmology.com\/cataract-surgery\/journal-articles\/noncompliance-with-prescribed-eyedrop-regimens-among-patients-undergoing-cataract-surgery-prevalence-consequences-and-solutions\/ [Accessed October 2, 2024].","DOI":"10.17925\/USOR.2020.13.1.18"},{"key":"4309_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/ICU.0000000000000708","volume":"32","author":"KK Assil","year":"2021","unstructured":"Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2021;32:S1.","journal-title":"Curr Opin Ophthalmol"},{"key":"4309_CR6","doi-asserted-by":"crossref","unstructured":"Massa S, Smits DJ, Nguyen AT, Patil SA, Chen EM, Shorstein NH, et al. Cost analysis of dropless cataract surgery prophylaxis with intracameral antibiotics and subconjunctival steroids. J Cataract Refract Surg. 2024. https:\/\/journals.lww.com\/10.1097\/j.jcrs.0000000000001526 [accessed October 2, 2024].","DOI":"10.1097\/j.jcrs.0000000000001526"},{"key":"4309_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/j.jcrs.0000000000000757","volume":"48","author":"DF Chang","year":"2022","unstructured":"Chang DF, Rhee DJ. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey. J Cataract Refract Surg. 2022;48:3.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jcrs.2011.03.049","volume":"37","author":"M Dieleman","year":"2011","unstructured":"Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PWT. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37:1589.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20522-y","volume":"12","author":"P Choopong","year":"2022","unstructured":"Choopong P, Taetrongchit N, Boonsopon S, Nimkarn A, Srisukkosalin K, Chonpimai P, et al. Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial. Sci Rep. 2022;12:16471.","journal-title":"Sci Rep"},{"key":"4309_CR10","first-page":"1127","volume":"66","author":"H Khan","year":"2016","unstructured":"Khan H, Alam M, Khan A. Comparison of the safety and efficacy of single injection of subtenon triamcinolone and topical dexamethasone in reducing postoperative inflammation after phacoemulsification and intraocular lens implantation. J Pak Med Assoc. 2016;66:1127\u20131127.","journal-title":"J Pak Med Assoc"},{"key":"4309_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/IAE.0b013e3181c969b4","volume":"30","author":"C Takata","year":"2010","unstructured":"Takata C, Messias A, Folgosa MS, Lucena LR, Lucena DR, Scott IU, et al. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. RETINA. 2010;30:562.","journal-title":"RETINA"},{"key":"4309_CR12","doi-asserted-by":"crossref","unstructured":"Walters T, Bafna S. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;7. Available at: https:\/\/www.omicsonline.org\/open-access\/efficacy-and-safety-of-sustained-release-dexamethasone-for-the-treatment-of-ocular-pain-and-inflammation-after-cataract-surgery-re-2155-9570-1000572.php?aid=79302 [accessed October 6, 2024].","DOI":"10.4172\/2155-9570.1000572"},{"key":"4309_CR13","doi-asserted-by":"crossref","unstructured":"Brant A, Kolomeyer N, Goldberg JL, Haller J, Lee CS, Lee AY, et al. Evaluating visual acuity in the American Academy of Ophthalmology IRIS\u00ae Registry. Ophthalmol Sci. 2024;4:100352.","DOI":"10.1016\/j.xops.2023.100352"},{"key":"4309_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/aos.14175","volume":"98","author":"J-M Lindholm","year":"2020","unstructured":"Lindholm J-M, Taipale C, Ylinen P, Tuuminen R. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98:36\u201342.","journal-title":"Acta Ophthalmol"},{"key":"4309_CR15","doi-asserted-by":"crossref","unstructured":"Shorstein NH, McCabe SE, Alavi M, Kwan ML, Chandra NS. Triamcinolone acetonide subconjunctival injection as stand-alone inflammation prophylaxis after phacoemulsification cataract surgery. Ophthalmology. 2024. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0161642024002069 [accessed June 14, 2024].","DOI":"10.1016\/j.ophtha.2024.03.025"},{"key":"4309_CR16","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1055\/s-0043-1771043","volume":"15","author":"EK Wotipka","year":"2023","unstructured":"Wotipka EK, Wright AJ, Fan JZ, Fuhriman D, Chuang AZ, Lindhorst GC, et al. Postoperative complications of true dropless cataract surgery versus standard topical drops. J Acad Ophthalmol. 2023;15:e144\u2013e153.","journal-title":"J Acad Ophthalmol"},{"key":"4309_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jcrs.2018.05.015","volume":"44","author":"LHP Wielders","year":"2018","unstructured":"Wielders LHP, Schouten JSAG, Winkens B, van den Biggelaar FJHM, Veldhuizen CA, Murta JCN, et al. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44:836.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR18","doi-asserted-by":"crossref","unstructured":"Rossetti L, Autelitano A. Cystoid macular edema following cataract surgery: Curr Opin Ophthalmol. https:\/\/journals.lww.com\/co-ophthalmology\/fulltext\/2000\/02000\/cystoid_macular_edema_following_cataract_surgery.10.aspx [accessed June 25, 2025].","DOI":"10.1097\/00055735-200002000-00010"},{"key":"4309_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-019-0170-2","volume":"9","author":"K Neatrour","year":"2019","unstructured":"Neatrour K, McAlpine A, Owens TB, Trivedi RH, Poole Perry LJ. Evaluation of the etiology of persistent iritis after cataract surgery. J Ophthalmic Inflamm Infect. 2019;9:4.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"4309_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ajo.2021.10.004","volume":"234","author":"M Soifer","year":"2022","unstructured":"Soifer M, Mousa HM, Jammal AA, Savarain C, Perez VL. Diagnosis and management of idiopathic persistent iritis after cataract surgery (IPICS). Am J Ophthalmol. 2022;234:250\u20138.","journal-title":"Am J Ophthalmol"},{"key":"4309_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2016.08.036","volume":"171","author":"S Pershing","year":"2016","unstructured":"Pershing S, Morrison DE, Hernandez-Boussard T. Cataract surgery complications and revisit rates among three states. Am J Ophthalmol. 2016;171:130\u20138.","journal-title":"Am J Ophthalmol"},{"key":"4309_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcrs.2017.10.049","volume":"44","author":"MA Mahr","year":"2018","unstructured":"Mahr MA, Hodge DO, Erie JC. Racial\/ethnic differences in rates of complex cataract surgery among United States Medicare beneficiaries. J Cataract Refract Surg. 2018;44:140\u20133.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ophtha.2010.07.023","volume":"118","author":"PB Greenberg","year":"2011","unstructured":"Greenberg PB, Tseng VL, Wu W-C, Liu J, Jiang L, Chen CK, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States Veterans. Ophthalmology. 2011;118:507\u201314.","journal-title":"Ophthalmology"},{"key":"4309_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/ceo.13702","volume":"48","author":"AT Fung","year":"2020","unstructured":"Fung AT, Tran T, Lim LL, Samarawickrama C, Arnold J, Gillies M, et al. Local delivery of corticosteroids in clinical ophthalmology: a review. Clin Exp Ophthalmol. 2020;48:366\u2013401.","journal-title":"Clin Exp Ophthalmol"},{"key":"4309_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/eye.2009.182","volume":"24","author":"A Karalezli","year":"2010","unstructured":"Karalezli A, Borazan M, Kucukerdonmez C, Akman A, Akova YA. Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery. Eye. 2010;24:619\u201323.","journal-title":"Eye"},{"key":"4309_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","volume":"58","author":"W Kiddee","year":"2013","unstructured":"Kiddee W, Trope GE, Sheng L, Beltran-Agullo L, Smith M, Strungaru MH, et al. Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol. 2013;58:291\u2013310.","journal-title":"Surv Ophthalmol"},{"key":"4309_CR27","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2147\/OPTH.S426200","volume":"17","author":"AM Wu","year":"2023","unstructured":"Wu AM, Pitts KM, Pineda R, Chen SH, Wang M, Johnson G, et al. Steroid response following dropless cataract surgery using subconjunctival triamcinolone. Clin Ophthalmol Auckl Nz. 2023;17:2803\u201314.","journal-title":"Clin Ophthalmol Auckl Nz"},{"key":"4309_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40123-013-0020-5","volume":"2","author":"U Pleyer","year":"2013","unstructured":"Pleyer U, Ursell PG, Rama P. Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?. Ophthalmol Ther. 2013;2:55\u201372.","journal-title":"Ophthalmol Ther"},{"key":"4309_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jcrs.2010.10.051","volume":"37","author":"DF Chang","year":"2011","unstructured":"Chang DF, Tan JJ, Tripodis Y. Risk factors for steroid response among cataract patients. J Cataract Refract Surg. 2011;37:675\u201381.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","volume":"125","author":"E Donnenfeld","year":"2018","unstructured":"Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, phase III trial. Ophthalmology. 2018;125:799\u2013806.","journal-title":"Ophthalmology"},{"key":"4309_CR31","doi-asserted-by":"crossref","unstructured":"Mencucci R, Stefanini S, Favuzza E, Cennamo M, De Vitto C, Mossello E. Beyond vision: cataract and health status in old age, a narrative review. Front Med. 2023;10. https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2023.1110383\/full [accessed October 2, 2024].","DOI":"10.3389\/fmed.2023.1110383"},{"key":"4309_CR32","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jcrs.2013.11.033","volume":"40","author":"M Grimfors","year":"2014","unstructured":"Grimfors M, Mollazadegan K, Lundstr\u00f6m M, Kugelberg M. Ocular comorbidity and self-assessed visual function after cataract surgery. J Cataract Refract Surg. 2014;40:1163\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"4309_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/PPA.S126283","volume":"11","author":"JP Gira","year":"2017","unstructured":"Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (DextenzaTM): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487\u201394.","journal-title":"Patient Prefer Adherence"},{"key":"4309_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.13055","volume":"94","author":"S Porela-Tiihonen","year":"2016","unstructured":"Porela-Tiihonen S, Kokki H, Kaarniranta K, Kokki M. Recovery after cataract surgery. Acta Ophthalmol. 2016;94:1\u201334.","journal-title":"Acta Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04309-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:20:32Z","timestamp":1775661632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04309-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4309"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04309-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}